Why the Stop Loss Decision is Critical for Larger Self-Funded Employers

This edition of MRM's "Ask the Expert” features advice from Trion Group. Please send questions to Modern Restaurant Management (MRM) magazine Executive Editor Barbara Castiglia at bcastiglia@modernrestaurantmanagement.com.There are stories nearly every day in the media about innovations in healthcare, breakthrough treatments, and in some cases cures for various illnesses. For example, think of all the new cancer treatments like Keytruda and Opdivo that have come to market in recent years that extend life. What’s frequently omitted however, is the cost of some of these miracle cures.

Over the past five years, nearly every one of our restaurant groups has incurred at least one cancer claim of at least $300,000. We also have seen a dramatic increase in the frequency of claims exceeding $1,000,000. 

What’s driving these stop loss renewal increases of million dollar claims is the specialty drug pipeline and gene therapies. This issue impacts employers in all business…